1. Home
  2. SAFT vs SDGR Comparison

SAFT vs SDGR Comparison

Compare SAFT & SDGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Safety Insurance Group Inc.

SAFT

Safety Insurance Group Inc.

HOLD

Current Price

$103.51

Market Cap

1.1B

Sector

Finance

ML Signal

HOLD

SDGR

Schrodinger Inc.

HOLD

Current Price

$17.78

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SAFT
SDGR
Founded
1979
1990
Country
United States
United States
Employees
N/A
N/A
Industry
Property-Casualty Insurers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.1B
IPO Year
2002
2020

Fundamental Metrics

Financial Performance
Metric
SAFT
SDGR
Price
$103.51
$17.78
Analyst Decision
Buy
Analyst Count
0
9
Target Price
N/A
$21.00
AVG Volume (30 Days)
332.3K
893.3K
Earning Date
05-05-2026
05-05-2026
Dividend Yield
4.88%
N/A
EPS Growth
40.17
45.14
EPS
N/A
N/A
Revenue
$1,263,732,000.00
$255,869,000.00
Revenue This Year
N/A
$0.76
Revenue Next Year
N/A
$4.60
P/E Ratio
N/A
N/A
Revenue Growth
12.83
23.29
52 Week Low
$67.04
$10.95
52 Week High
$103.63
$23.02

Technical Indicators

Market Signals
Indicator
SAFT
SDGR
Relative Strength Index (RSI) N/A N/A
Support Level N/A N/A
Resistance Level N/A N/A
Average True Range (ATR) 0.00 0.00
MACD 0.00 0.00
Stochastic Oscillator 0.00 0.00

Price Performance

Historical Comparison
SAFT
SDGR

About SAFT Safety Insurance Group Inc.

Safety Insurance Group Inc is a provider of private passenger automobile, commercial automobile, and homeowners insurance in Massachusetts. The company also offers property and casualty insurance products, including commercial automobiles, homeowners, dwelling fire, umbrella, and business owner policies. The company operates in the business segment of Property and casualty insurance operations.

About SDGR Schrodinger Inc.

Schrodinger Inc is a healthcare-based software company. It offers software solutions designed to support and accelerate the discovery, design, and optimization of molecules. The company operates in two reportable segments: Software and Drug Discovery. The software segment is focused on selling software to transform drug discovery across the life sciences industry, as well as to customers in materials science industries. The drug discovery segment is focused on generating revenue from a diverse portfolio of preclinical and clinical programs, internally and through collaborations, that have various stages of discovery and development. The majority of the company's revenue is derived from the Software segment. Geographically, it derives the maximum revenue from the United States.

Share on Social Networks: